1146 feeds
357 categories
1823 articles (<24 hours)
21 registered users

Use the Mobile version

Follow our Twitter feed

View our Linkpartners


Register | Retrieve


RSS FeedsAbbVie Has It All: Growth, Dividend Growth And Compelling Valuation
(WorldNews Health)


26 june 2019 15:08:22

AbbVie Has It All: Growth, Dividend Growth And Compelling Valuation
(WorldNews Health)

Introduction I have held AbbVie (ABBV) since it was originally spun off from Abbott Labs. Moreover, I have been aggressively adding to my position for clients needing current income and dividend growth. All in all, it has been an excellent performer in spite of the fact that it is being ridiculously undervalued by Mr. Market. No matter what widely accepted valuation measurement I look at, the stock appears insanely cheap. As of Monday´s close (June 24, 2019), AbbVie was trading at a blended P/E ratio based on adjusted operating earnings of 9.4 offering a dividend yield of 5.5%. This represents a significant discount to its historical normal P/E ratio of 14.5 and its intrinsic value P/E ratio...

24 viewsCategory: Science > Medicine
Does salt sold in India contain cyanide? US lab report claims so
(WorldNews Health)
What To Make Of AbbVie Buying Allergan
(WorldNews Health)
blog comments powered by Disqus

Copyright © 2008 - 2020 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten